Advanced Oncotherapy (AVO)

Sector:

Health Care

 1.93p
   
  • Change Today:
      0.000p
  • 52 Week High: 25.00
  • 52 Week Low: 1.75
  • Currency: UK Pounds
  • Shares Issued: 542.57m
  • Volume: 0
  • Market Cap: £10.44m

AVO Overview

Advanced Oncotherapy is a specialist developer and provider of a breakthrough proton therapy system, the LIGHT system, which is the result of 25 years of work at CERN and ADAM. Our focus is on developing and supplying technologies to maximise the destructive effect of radiation on tumours whilst minimising damage to the patient's healthy tissues.

Key Personnel

CEO: Nicolas Serandour
Executive Chairman: Michael J Sinclair
Non-Executive Dir: Lori Cross, Hans von Celsing, Enrico Cipro Vanni , Nick Plowman, RenHua Zhang, Steve Myers OBE , Michael Bradfield

Contact Details

Address: 143 Harley Street, Ground Floor, London, United Kingdom, W1G 6BH
Phone: 020 7034 1949
Fax: 020 7034 1941
Website: www.avoplc.com

Listings

Sector: Health Care(LSE)
ISIN: GB00BD6SX109

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

AVO Market Data

Currency UK Pounds
Share Price 1.93p
Change Today 0.000p
% Change 0.00 %
52 Week High 25.00
52 Week Low 1.75
Volume 0
Shares Issued 542.57m
Market Cap £10.44m

AVO Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend
74.77% below the market average74.77% below the market average74.77% below the market average74.77% below the market average74.77% below the market average
35.14% below the sector average35.14% below the sector average35.14% below the sector average35.14% below the sector average35.14% below the sector average
Income Not Available
Growth Not Available

AVO Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

AVO Key Personnel

CEO Nicolas Serandour

Top of Page